Key result
PGC-1alpha overexpression increased fatty acid oxidation in human skeletal muscle cells (P<0.05) but did not correct the 30% absolute reduction in fatty acid oxidation associated with extreme obesity.
Why the study?
Does PGC-1alpha overexpression improve fatty acid oxidation in primary human skeletal muscle cells from extremely obese individuals?
Does PGC-1alpha overexpression improve fatty acid oxidation in primary human skeletal muscle cells from extremely obese individuals?
p-value: p=<0.05
Reduced mitochondrial content is related to impaired fatty acid oxidation in skeletal muscle cells from obese individuals, and increasing PGC-1alpha does not fully correct this deficit.
PGC-1α overexpression insufficient to normalize obesity-linked fatty acid oxidation deficits in vitro; leaves open multifactorial mitochondrial targets for future study.
OBJECTIVE: To determine whether the obesity-related decrement in fatty acid oxidation (FAO) in primary human skeletal muscle cells (HSkMC) is linked with lower mitochondrial content and whether this deficit could be corrected via overexpression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha). RESEARCH DESIGN AND METHODS: FAO was studied in HSkMC from lean (BMI 22.4 +/- 0.9 kg/m(2); N = 12) and extremely obese (45.3 +/- 1.4 kg/m(2); N = 9) subjects. Recombinant adenovirus was used to increase HSkMC PGC-1alpha expression (3.5- and 8.0-fold), followed by assessment of mitochondrial content (mtDNA and cytochrome C oxidase IV [COXIV]), complete ((14)CO(2) production from labeled oleate), and incomplete (acid soluble metabolites [ASM]) FAO, and glycerolipid synthesis. RESULTS: Obesity was associated with a 30% decrease (P < 0.05) in complete FAO, which was accompanied by higher relative rates of incomplete FAO ([(14)C]ASM production/(14)CO(2)), increased partitioning of fatty acid toward storage, and lower (P < 0.05) mtDNA (-27%), COXIV (-35%), and mitochondrial transcription factor (mtTFA) (-43%) protein levels. PGC-1alpha overexpression increased (P < 0.05) FAO, mtDNA, COXIV, mtTFA, and fatty acid incorporation into triacylglycerol in both lean and obese groups. Perturbations in FAO, triacylglycerol synthesis, mtDNA, COXIV, and mtTFA in obese compared with lean HSkMC persisted despite PGC-1alpha overexpression. When adjusted for mtDNA and COXIV content, FAO was equivalent between lean and obese groups. CONCLUSION: Reduced mitochondrial content is related to impaired FAO in HSkMC derived from obese individuals. Increasing PGC-1alpha protein levels did not correct the obesity-related absolute reduction in FAO or mtDNA content, implicating mechanisms other than PGC-1alpha abundance.
No takes yet. Share an insight, caveat, or question.
Consitt et al. (2010) studied Obesity (n=21). PGC-1alpha overexpression vs. Baseline/control cells was evaluated on Complete fatty acid oxidation (FAO) (p=<0.05). PGC-1alpha overexpression increased fatty acid oxidation in human skeletal muscle cells (P<0.05) but did not correct the 30% absolute reduction in fatty acid oxidation associated with extreme obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: